| methylprednisolone sodium succinate / Generic mfg. |
ACTRN12622001186741: Autologous Stem Cell Transplant in Neuro-Inflammatory diseases other than multiple sclerosis |
|
|
| Not yet recruiting | N/A | 5 | | | The Alfred- Melbourne, The Alfred-Melbourne | Neuro-Inflammatory disease | | | | |
NCT00937157: Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) |
|
|
| Completed | N/A | 12 | US | Copaxone, Glatiramer acetate | University at Buffalo, Teva Neuroscience, Inc. | Multiple Sclerosis | 07/10 | 04/11 | | |
NCT00764413: Chronotherapy in Acute Multiple Sclerosis (MS) Attack |
|
|
| Terminated | N/A | 57 | Europe | methylprednisolone, Solu-Medrol. ACT-nr:H02A B04, Sodium chlorid, ATC: B05B B01 | Sykehuset Innlandet HF | Multiple Sclerosis | 07/12 | 07/12 | | |
MSECP, NCT02296346: Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis |
|
|
| Terminated | N/A | 13 | US | SoluMedrol, Corticosteroids, Extracorporeal Photopheresis, ECP, Cellex machine, Therakos | University of Utah, Mallinckrodt | Secondary Progressive Multiple Sclerosis | 06/17 | 05/18 | | |
NCT03530462: To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI |
|
|
| Completed | N/A | 22 | RoW | rituximab, rituximab injection, cyclophosphamide, cyclophosphamide injection, Steroids, methylprednisolone, Intravenous immunoglobulin, IVIG | First Affiliated Hospital of Zhejiang University | Cognitive Impairment, Autoimmune Encephalitis | 02/18 | 02/18 | | |
NCT01900093: Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses |
|
|
| Unknown status | N/A | 10 | US | Acthar Gel, Repository corticotrophin injection | Aaron Miller, Mallinckrodt | Multiple Sclerosis | 03/18 | 03/18 | | |
| Withdrawn | N/A | 0 | US | Blood sample collection for coagulation profile, Clinical data collection | St. Joseph's Hospital and Medical Center, Phoenix | Multiple Sclerosis | 12/21 | 03/22 | | |
NCT06068829: Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders |
|
|
| Not yet recruiting | N/A | 80 | NA | Inebilizumab, Rituximab(RTX) | Feng Jinzhou | Neuromyelitis Optica Spectrum Disorders | 06/24 | 06/25 | | |
NCT06118398: Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders |
|
|
| Not yet recruiting | N/A | 24 | NA | Intravenous methylprednisolone (IVMP) and Efgartigimod, IVMP | Feng Jinzhou | Neuromyelitis Optica, Efgartigimod | 11/24 | 05/25 | | |
NCT05891379: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders |
|
|
| Not yet recruiting | N/A | 50 | NA | Inebilizumab, oral immunosuppressant | Xuanwu Hospital, Beijing, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Neuromyelitis Optica Spectrum Disorder | 07/25 | 07/25 | | |
